BILBAO – Yesil Science, a participant in the Garanti BBVA Partners program, unveils FluAI, a groundbreaking mobile health application powered by artificial intelligence (AI), according to a press release published on EuropaWire.
FluAI is designed to address upper respiratory tract infections, including colds and flu, by providing users with personalized information and recommendations based on AI analysis of patient-submitted photographs and symptom data. The app aims to reduce unnecessary antibiotic usage and includes a coronavirus risk detection feature.
Joseph Green, Founder of Green Science, the developer of FluAI, commented, “FluAI was created by a team of experienced professionals from diverse backgrounds, including physicians and engineers. We also benefit from the guidance of universities and academics.”
Green emphasized the collaboration with Garanti BBVA Partners and other esteemed institutions such as NVIDIA, TĂśSÄ°AD, Technopark Istanbul, and the Istanbul Chamber of Industry. He added, “We are currently conducting a clinical study, and look forward to sharing the results.”
Yesil Science was established with the mission of pioneering innovative healthcare solutions that integrate medicine, art, and technology.
